BioCentury
ARTICLE | Clinical News

Thyrogen thyrotropin alpha regulatory update

August 1, 2011 7:00 AM UTC

EMA's CHMP said Sanofi's Genzyme Corp. subsidiary notified the committee that the supply shortage for thyroid cancer treatment Thyrogen thyrotropin alfa will continue to be restricted until 2012. In ...